Literature DB >> 20184954

RhoH plays distinct roles in T-cell migrations induced by different doses of SDF1 alpha.

Hong Wang1, Xin Zeng, Zhigang Fan, Bing Lim.   

Abstract

Hematopoietic-specific RhoGTPase RhoH displays an important role in regulating T-cell development, a process that is accompanied by ordered and directed migration of progenitors through thymus. While RhoGTPases are key regulators of cytokinesis, the precise role of RhoH in T-cell migration is unknown. Here, by using Jurkat cell migration as a model, we found that RhoH is required for cell migration in response to the high concentration of SDF1 alpha but displays inhibitory roles in regulating migration in the absence of SDF1 alpha or in the range of low concentrations. We further found that RhoH-mediated migration requires PAK1 but not ITK. Indeed, both the low and high concentrations of SDF1 alpha activate PAK1 but only the high concentration-induced activation of PAK1 requires RhoH. Further study of the RhoH-PAK interaction revealed that RhoH is able to bind and activate PAK1, indicating that RhoH plays a positive role in response to the high concentration of SDF1 alpha. In contrast, at rest, RhoH indirectly inhibits Slp76/ITK activity through its modulation on TCR signaling, supporting a negative regulatory role for RhoH when SDF1 alpha is insufficient to activate the RhoH-PAK1 pathway. Together, our study uncovered a dual role for RhoH in SDF1 alpha signaling in T-cell responses. (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184954     DOI: 10.1016/j.cellsig.2010.02.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.

Authors:  Anja Troeger; Amy J Johnson; Jenna Wood; William G Blum; Leslie A Andritsos; John C Byrd; David A Williams
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

2.  Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.

Authors:  Hong Wang; Shengjie Bian; Chung S Yang
Journal:  Carcinogenesis       Date:  2011-09-28       Impact factor: 4.944

3.  Opposing roles for RhoH GTPase during T-cell migration and activation.

Authors:  Christina M Baker; William A Comrie; Young-Min Hyun; Hung-Li Chung; Christine A Fedorchuk; Kihong Lim; Cord Brakebusch; James L McGrath; Richard E Waugh; Martin Meier-Schellersheim; Minsoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 4.  Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders.

Authors:  Anja Troeger; David A Williams
Journal:  Exp Cell Res       Date:  2013-07-11       Impact factor: 3.905

5.  Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy.

Authors:  Sylvie Galiègue-Zouitina; Qiangwei Fu; Céline Carton-Latreche; Nicolas Poret; Meyling Cheok; Frédéric Leprêtre; Martin Figeac; Bruno Quesnel; Hassiba El Bouazzati; Carl S Shelley
Journal:  EJHaem       Date:  2021-01-20

6.  Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.

Authors:  G B Martinelli; D Olivari; A D Re Cecconi; L Talamini; L Ottoboni; S H Lecker; C Stretch; V E Baracos; O F Bathe; A Resovi; R Giavazzi; L Cervo; R Piccirillo
Journal:  Oncogene       Date:  2016-05-23       Impact factor: 9.867

7.  Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration.

Authors:  P J Bhavsar; E Infante; A Khwaja; A J Ridley
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

8.  An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration.

Authors:  Virginia Tajadura-Ortega; Ritu Garg; Richard Allen; Claudia Owczarek; Michael D Bright; Samuel Kean; Aisyah Mohd-Noor; Anita Grigoriadis; Timothy C Elston; Klaus M Hahn; Anne J Ridley
Journal:  BMC Biol       Date:  2018-03-06       Impact factor: 7.431

9.  Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.

Authors:  Kateřina Kuželová; Dana Grebeňová; Aleš Holoubek; Pavla Röselová; Adam Obr
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.